Efficacy and safety of intradermal vaccination against porcine circovirus type 2 and Mycoplasma hyopneumoniae under combined exposure field conditions
Abstract Background Porcine circovirus 2 (PCV2) and Mycoplasma hyopneumoniae (M hyo) are two of the most important swine pathogens with variable clinical presence in swine farms globally, affecting health and performance of pigs under field conditions. The primary objective of this study was to asse...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Porcine Health Management |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40813-025-00431-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850145542739329024 |
|---|---|
| author | Panagiotis Tassis Suzanne Pel Dimitrios Floros Kim ter Haar Qi Cao Ioannis Tsakmakidis Vassileios Papatsiros Niki Ntarampa Ioannis Arsenakis Eleni D. Tzika |
| author_facet | Panagiotis Tassis Suzanne Pel Dimitrios Floros Kim ter Haar Qi Cao Ioannis Tsakmakidis Vassileios Papatsiros Niki Ntarampa Ioannis Arsenakis Eleni D. Tzika |
| author_sort | Panagiotis Tassis |
| collection | DOAJ |
| description | Abstract Background Porcine circovirus 2 (PCV2) and Mycoplasma hyopneumoniae (M hyo) are two of the most important swine pathogens with variable clinical presence in swine farms globally, affecting health and performance of pigs under field conditions. The primary objective of this study was to assess the efficacy of a ready to use intradermal (ID) vaccine (Porcilis PCV M Hyo ID, MSD Animal Health, The Netherlands) against PCV2 associated disease and M hyo associated enzootic pneumonia under practical (field) conditions. In addition, the safety of the test product was clinically assessed, as the study animals were examined for general and local side effects after vaccination. A total of 678 animals in a Greek farrow to finish farm were equally divided in two trial groups (test and control group). Test group animals received the test vaccine at the age of three weeks, while control group animals remained unvaccinated. Parameters regarding health [lung lesion score (LLS) and pleurisy scoring, PCV2 viraemia and shedding] and performance [body weight (BW), average daily weight gain (ADWG)] were recorded and evaluated. Results Vaccination improved the ADWG during both the finishing period (improvement by 34 g; p < 0.0001), and the overall period (increase by 24 g; p < 0.0001). Moreover, reduced mean LLS values (p < 0.0001), as well as reduced percentage of animals with pleurisy (p = 0.0082) and a decrease in PCV2 viraemia (p < 0.0001) and viral shedding (p = 0.0181) were observed in vaccinated animals when compared with the unvaccinated controls. As regards safety, a slight local skin reaction at the site of vaccination was detected and in two pigs a mild systemic reaction was reported with full recovery. Conclusions Findings suggested that the test vaccine is safe and effective against both PCV2 and M hyo associated diseases in vivo, thus it’s use as part of a vaccination programme under field conditions is expected to improve respective health and performance parameters in pigs. |
| format | Article |
| id | doaj-art-feeab14f937740bba33b89e4b68abf46 |
| institution | OA Journals |
| issn | 2055-5660 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | BMC |
| record_format | Article |
| series | Porcine Health Management |
| spelling | doaj-art-feeab14f937740bba33b89e4b68abf462025-08-20T02:28:04ZengBMCPorcine Health Management2055-56602025-04-0111111210.1186/s40813-025-00431-yEfficacy and safety of intradermal vaccination against porcine circovirus type 2 and Mycoplasma hyopneumoniae under combined exposure field conditionsPanagiotis Tassis0Suzanne Pel1Dimitrios Floros2Kim ter Haar3Qi Cao4Ioannis Tsakmakidis5Vassileios Papatsiros6Niki Ntarampa7Ioannis Arsenakis8Eleni D. Tzika9Farm Animals Clinic, School of Veterinary Medicine, Aristotle University of ThessalonikiMSD Animal HealthFarm Animals Clinic, School of Veterinary Medicine, Aristotle University of ThessalonikiMSD Animal HealthMSD Animal HealthFarm Animals Clinic, School of Veterinary Medicine, Aristotle University of ThessalonikiClinic of Medicine, School of Veterinary Medicine, University of ThessalyFarm Animals Clinic, School of Veterinary Medicine, Aristotle University of ThessalonikiLaboratory of Anatomy & Physiology of Farm Animals, Agricultural University of AthensFarm Animals Clinic, School of Veterinary Medicine, Aristotle University of ThessalonikiAbstract Background Porcine circovirus 2 (PCV2) and Mycoplasma hyopneumoniae (M hyo) are two of the most important swine pathogens with variable clinical presence in swine farms globally, affecting health and performance of pigs under field conditions. The primary objective of this study was to assess the efficacy of a ready to use intradermal (ID) vaccine (Porcilis PCV M Hyo ID, MSD Animal Health, The Netherlands) against PCV2 associated disease and M hyo associated enzootic pneumonia under practical (field) conditions. In addition, the safety of the test product was clinically assessed, as the study animals were examined for general and local side effects after vaccination. A total of 678 animals in a Greek farrow to finish farm were equally divided in two trial groups (test and control group). Test group animals received the test vaccine at the age of three weeks, while control group animals remained unvaccinated. Parameters regarding health [lung lesion score (LLS) and pleurisy scoring, PCV2 viraemia and shedding] and performance [body weight (BW), average daily weight gain (ADWG)] were recorded and evaluated. Results Vaccination improved the ADWG during both the finishing period (improvement by 34 g; p < 0.0001), and the overall period (increase by 24 g; p < 0.0001). Moreover, reduced mean LLS values (p < 0.0001), as well as reduced percentage of animals with pleurisy (p = 0.0082) and a decrease in PCV2 viraemia (p < 0.0001) and viral shedding (p = 0.0181) were observed in vaccinated animals when compared with the unvaccinated controls. As regards safety, a slight local skin reaction at the site of vaccination was detected and in two pigs a mild systemic reaction was reported with full recovery. Conclusions Findings suggested that the test vaccine is safe and effective against both PCV2 and M hyo associated diseases in vivo, thus it’s use as part of a vaccination programme under field conditions is expected to improve respective health and performance parameters in pigs.https://doi.org/10.1186/s40813-025-00431-yPigsIntradermal vaccinationPorcine circovirus type 2Mycoplasma hyopneumoniaeLung lesionsPleurisy |
| spellingShingle | Panagiotis Tassis Suzanne Pel Dimitrios Floros Kim ter Haar Qi Cao Ioannis Tsakmakidis Vassileios Papatsiros Niki Ntarampa Ioannis Arsenakis Eleni D. Tzika Efficacy and safety of intradermal vaccination against porcine circovirus type 2 and Mycoplasma hyopneumoniae under combined exposure field conditions Porcine Health Management Pigs Intradermal vaccination Porcine circovirus type 2 Mycoplasma hyopneumoniae Lung lesions Pleurisy |
| title | Efficacy and safety of intradermal vaccination against porcine circovirus type 2 and Mycoplasma hyopneumoniae under combined exposure field conditions |
| title_full | Efficacy and safety of intradermal vaccination against porcine circovirus type 2 and Mycoplasma hyopneumoniae under combined exposure field conditions |
| title_fullStr | Efficacy and safety of intradermal vaccination against porcine circovirus type 2 and Mycoplasma hyopneumoniae under combined exposure field conditions |
| title_full_unstemmed | Efficacy and safety of intradermal vaccination against porcine circovirus type 2 and Mycoplasma hyopneumoniae under combined exposure field conditions |
| title_short | Efficacy and safety of intradermal vaccination against porcine circovirus type 2 and Mycoplasma hyopneumoniae under combined exposure field conditions |
| title_sort | efficacy and safety of intradermal vaccination against porcine circovirus type 2 and mycoplasma hyopneumoniae under combined exposure field conditions |
| topic | Pigs Intradermal vaccination Porcine circovirus type 2 Mycoplasma hyopneumoniae Lung lesions Pleurisy |
| url | https://doi.org/10.1186/s40813-025-00431-y |
| work_keys_str_mv | AT panagiotistassis efficacyandsafetyofintradermalvaccinationagainstporcinecircovirustype2andmycoplasmahyopneumoniaeundercombinedexposurefieldconditions AT suzannepel efficacyandsafetyofintradermalvaccinationagainstporcinecircovirustype2andmycoplasmahyopneumoniaeundercombinedexposurefieldconditions AT dimitriosfloros efficacyandsafetyofintradermalvaccinationagainstporcinecircovirustype2andmycoplasmahyopneumoniaeundercombinedexposurefieldconditions AT kimterhaar efficacyandsafetyofintradermalvaccinationagainstporcinecircovirustype2andmycoplasmahyopneumoniaeundercombinedexposurefieldconditions AT qicao efficacyandsafetyofintradermalvaccinationagainstporcinecircovirustype2andmycoplasmahyopneumoniaeundercombinedexposurefieldconditions AT ioannistsakmakidis efficacyandsafetyofintradermalvaccinationagainstporcinecircovirustype2andmycoplasmahyopneumoniaeundercombinedexposurefieldconditions AT vassileiospapatsiros efficacyandsafetyofintradermalvaccinationagainstporcinecircovirustype2andmycoplasmahyopneumoniaeundercombinedexposurefieldconditions AT nikintarampa efficacyandsafetyofintradermalvaccinationagainstporcinecircovirustype2andmycoplasmahyopneumoniaeundercombinedexposurefieldconditions AT ioannisarsenakis efficacyandsafetyofintradermalvaccinationagainstporcinecircovirustype2andmycoplasmahyopneumoniaeundercombinedexposurefieldconditions AT elenidtzika efficacyandsafetyofintradermalvaccinationagainstporcinecircovirustype2andmycoplasmahyopneumoniaeundercombinedexposurefieldconditions |